StrainX Bioworks, a DeepTech company based in Bengaluru, India, has raised $13M in a Growth Equity round led by Prime Venture Partners & Leo Capital (co-led).
Quick Highlights
- Amount Raised: $13M
- Round Type: Growth Equity
- Lead Investor: Prime Venture Partners & Leo Capital (co-led)
- Other Investors: Not disclosed
- Industry: DeepTech
- Headquarters: Bengaluru, India
- Date Announced: 2026-05-28
About the Startup
StrainX Bioworks is a synthetic-biology (DeepTech) startup, headquartered in Bengaluru, India. It operates in the DeepTech sector and has now closed its Growth Equity round, with deal terms beyond the headline amount kept undisclosed.
Funding Breakdown
The company raised $13M in a Growth Equity round led by Prime Venture Partners & Leo Capital (co-led). Participating investors include Prime Venture Partners, Leo Capital. Valuation terms were not disclosed.
Use of Funds
StrainX Bioworks intends to deploy the capital toward product development, infrastructure.
Why This Funding Matters
For India’s startup ecosystem, the round reinforces continued investor appetite in DeepTech despite a selective overall funding market.
Investor Background
Prime Venture Partners & Leo Capital (co-led) is the lead backer in this round.
Funding Timeline
| Date | Round | Amount | Lead Investor |
|---|---|---|---|
| 2026-05-28 | Growth Equity | $13M | Prime Venture Partners & Leo Capital (co-led) |
Stay updated with the latest deals — visit thecourtroom.in for more funding news.
Disclaimer: This report is compiled from publicly available sources and is for informational purposes only; funding figures are as publicly reported and may be subject to change.
